Global Disease Control and Prevention Vaccine Market Research Report 2020

Global Disease Control and Prevention Vaccine Market Research Report 2020

Table of Contents
1 Disease Control and Prevention Vaccine Market Overview
1.1 Product Overview and Scope of Disease Control and Prevention Vaccine
1.2 Disease Control and Prevention Vaccine Segment by Type
1.2.1 Global Disease Control and Prevention Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Live-Attenuated
1.2.3 Inactivated
1.2.4 Recombinant Sub Unit and Toxoid
1.3 Disease Control and Prevention Vaccine Segment by Application
1.3.1 Disease Control and Prevention Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Pediatric Vaccine
1.3.3 Adult Vaccine
1.4 Global Disease Control and Prevention Vaccine Market Size Estimates and Forecasts
1.4.1 Global Disease Control and Prevention Vaccine Revenue 2015-2026
1.4.2 Global Disease Control and Prevention Vaccine Sales 2015-2026
1.4.3 Disease Control and Prevention Vaccine Market Size by Region: 2020 Versus 2026
2 Global Disease Control and Prevention Vaccine Market Competition by Manufacturers
2.1 Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Disease Control and Prevention Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Disease Control and Prevention Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Disease Control and Prevention Vaccine Market Competitive Situation and Trends
2.5.1 Disease Control and Prevention Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Disease Control and Prevention Vaccine Players (Opinion Leaders)
3 Disease Control and Prevention Vaccine Retrospective Market Scenario by Region
3.1 Global Disease Control and Prevention Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Disease Control and Prevention Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Disease Control and Prevention Vaccine Market Facts & Figures by Country
3.3.1 North America Disease Control and Prevention Vaccine Sales by Country
3.3.2 North America Disease Control and Prevention Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Disease Control and Prevention Vaccine Market Facts & Figures by Country
3.4.1 Europe Disease Control and Prevention Vaccine Sales by Country
3.4.2 Europe Disease Control and Prevention Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Disease Control and Prevention Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Disease Control and Prevention Vaccine Sales by Region
3.5.2 Asia Pacific Disease Control and Prevention Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Disease Control and Prevention Vaccine Market Facts & Figures by Country
3.6.1 Latin America Disease Control and Prevention Vaccine Sales by Country
3.6.2 Latin America Disease Control and Prevention Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Disease Control and Prevention Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Country
3.7.2 Middle East and Africa Disease Control and Prevention Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Disease Control and Prevention Vaccine Historic Market Analysis by Type
4.1 Global Disease Control and Prevention Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Disease Control and Prevention Vaccine Price Market Share by Type (2015-2020)
4.4 Global Disease Control and Prevention Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Disease Control and Prevention Vaccine Historic Market Analysis by Application
5.1 Global Disease Control and Prevention Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Disease Control and Prevention Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Disease Control and Prevention Vaccine Business
6.1 GSK
6.1.1 Corporation Information
6.1.2 GSK Description, Business Overview and Total Revenue
6.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GSK Products Offered
6.1.5 GSK Recent Development
6.2 Merck & Co., Inc
6.2.1 Merck & Co., Inc Disease Control and Prevention Vaccine Production Sites and Area Served
6.2.2 Merck & Co., Inc Description, Business Overview and Total Revenue
6.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck & Co., Inc Products Offered
6.2.5 Merck & Co., Inc Recent Development
6.3 Pfizer
6.3.1 Pfizer Disease Control and Prevention Vaccine Production Sites and Area Served
6.3.2 Pfizer Description, Business Overview and Total Revenue
6.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Pfizer Products Offered
6.3.5 Pfizer Recent Development
6.4 Sanofi
6.4.1 Sanofi Disease Control and Prevention Vaccine Production Sites and Area Served
6.4.2 Sanofi Description, Business Overview and Total Revenue
6.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Products Offered
6.4.5 Sanofi Recent Development
6.5 AstraZeneca PLC
6.5.1 AstraZeneca PLC Disease Control and Prevention Vaccine Production Sites and Area Served
6.5.2 AstraZeneca PLC Description, Business Overview and Total Revenue
6.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 AstraZeneca PLC Products Offered
6.5.5 AstraZeneca PLC Recent Development
6.6 Sinovac Biotech Ltd
6.6.1 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Production Sites and Area Served
6.6.2 Sinovac Biotech Ltd Description, Business Overview and Total Revenue
6.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Sinovac Biotech Ltd Products Offered
6.6.5 Sinovac Biotech Ltd Recent Development
6.7 Astellas Pharma Inc
6.6.1 Astellas Pharma Inc Disease Control and Prevention Vaccine Production Sites and Area Served
6.6.2 Astellas Pharma Inc Description, Business Overview and Total Revenue
6.6.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Astellas Pharma Inc Products Offered
6.7.5 Astellas Pharma Inc Recent Development
6.8 Serum Institute of India Pvt. Ltd
6.8.1 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Production Sites and Area Served
6.8.2 Serum Institute of India Pvt. Ltd Description, Business Overview and Total Revenue
6.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Serum Institute of India Pvt. Ltd Products Offered
6.8.5 Serum Institute of India Pvt. Ltd Recent Development
6.9 Daiichi Sankyo
6.9.1 Daiichi Sankyo Disease Control and Prevention Vaccine Production Sites and Area Served
6.9.2 Daiichi Sankyo Description, Business Overview and Total Revenue
6.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Daiichi Sankyo Products Offered
6.9.5 Daiichi Sankyo Recent Development
7 Disease Control and Prevention Vaccine Manufacturing Cost Analysis
7.1 Disease Control and Prevention Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Disease Control and Prevention Vaccine
7.4 Disease Control and Prevention Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Disease Control and Prevention Vaccine Distributors List
8.3 Disease Control and Prevention Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Disease Control and Prevention Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Disease Control and Prevention Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Disease Control and Prevention Vaccine by Type (2021-2026)
10.2 Disease Control and Prevention Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Disease Control and Prevention Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Disease Control and Prevention Vaccine by Application (2021-2026)
10.3 Disease Control and Prevention Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Disease Control and Prevention Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Disease Control and Prevention Vaccine by Region (2021-2026)
10.4 North America Disease Control and Prevention Vaccine Estimates and Projections (2021-2026)
10.5 Europe Disease Control and Prevention Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Disease Control and Prevention Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Disease Control and Prevention Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Disease Control and Prevention Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Disease Control and Prevention Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Disease Control and Prevention Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Disease Control and Prevention Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Disease Control and Prevention Vaccine Manufacturers Covered in This Study
Table 5. Global Disease Control and Prevention Vaccine Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Disease Control and Prevention Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Disease Control and Prevention Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Disease Control and Prevention Vaccine Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Disease Control and Prevention Vaccine Sales Sites and Area Served
Table 11. Manufacturers Disease Control and Prevention Vaccine Product Types
Table 12. Global Disease Control and Prevention Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Disease Control and Prevention Vaccine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Disease Control and Prevention Vaccine Players
Table 16. Global Disease Control and Prevention Vaccine Sales (K Units) by Region (2015-2020)
Table 17. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Disease Control and Prevention Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Disease Control and Prevention Vaccine Sales by Country (2015-2020) (K Units)
Table 21. North America Disease Control and Prevention Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Disease Control and Prevention Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Disease Control and Prevention Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Disease Control and Prevention Vaccine Sales by Country (2015-2020) (K Units)
Table 25. Europe Disease Control and Prevention Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Disease Control and Prevention Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Disease Control and Prevention Vaccine Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Disease Control and Prevention Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Disease Control and Prevention Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Disease Control and Prevention Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Disease Control and Prevention Vaccine Sales by Country (2015-2020) (K Units)
Table 33. Latin America Disease Control and Prevention Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Disease Control and Prevention Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Disease Control and Prevention Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Disease Control and Prevention Vaccine Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Disease Control and Prevention Vaccine Sales (K Units) by Type (2015-2020)
Table 41. Global Disease Control and Prevention Vaccine Sales Share by Type (2015-2020)
Table 42. Global Disease Control and Prevention Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Disease Control and Prevention Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Type (2015-2020)
Table 45. Global Disease Control and Prevention Vaccine Sales (K Units) by Application (2015-2020)
Table 46. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Disease Control and Prevention Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. GSK Disease Control and Prevention Vaccine Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. GSK Main Product
Table 52. GSK Recent Development
Table 53. Merck & Co., Inc Disease Control and Prevention Vaccine Corporation Information
Table 54. Merck & Co., Inc Corporation Information
Table 55. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Merck & Co., Inc Main Product
Table 57. Merck & Co., Inc Recent Development
Table 58. Pfizer Disease Control and Prevention Vaccine Corporation Information
Table 59. Pfizer Corporation Information
Table 60. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Pfizer Main Product
Table 62. Pfizer Recent Development
Table 63. Sanofi Disease Control and Prevention Vaccine Corporation Information
Table 64. Sanofi Corporation Information
Table 65. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Sanofi Main Product
Table 67. Sanofi Recent Development
Table 68. AstraZeneca PLC Disease Control and Prevention Vaccine Corporation Information
Table 69. AstraZeneca PLC Corporation Information
Table 70. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. AstraZeneca PLC Main Product
Table 72. AstraZeneca PLC Recent Development
Table 73. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Corporation Information
Table 74. Sinovac Biotech Ltd Corporation Information
Table 75. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Sinovac Biotech Ltd Main Product
Table 77. Sinovac Biotech Ltd Recent Development
Table 78. Astellas Pharma Inc Disease Control and Prevention Vaccine Corporation Information
Table 79. Astellas Pharma Inc Corporation Information
Table 80. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Astellas Pharma Inc Main Product
Table 82. Astellas Pharma Inc Recent Development
Table 83. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Corporation Information
Table 84. Serum Institute of India Pvt. Ltd Corporation Information
Table 85. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Serum Institute of India Pvt. Ltd Main Product
Table 87. Serum Institute of India Pvt. Ltd Recent Development
Table 88. Daiichi Sankyo Disease Control and Prevention Vaccine Corporation Information
Table 89. Daiichi Sankyo Corporation Information
Table 90. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Daiichi Sankyo Main Product
Table 92. Daiichi Sankyo Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Disease Control and Prevention Vaccine Distributors List
Table 96. Disease Control and Prevention Vaccine Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Disease Control and Prevention Vaccine Sales (K Units) Forecast by Type (2021-2026)
Table 101. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Disease Control and Prevention Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Disease Control and Prevention Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Disease Control and Prevention Vaccine Sales (K Units) Forecast by Application (2021-2026)
Table 105. Global Disease Control and Prevention Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Disease Control and Prevention Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 107. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Disease Control and Prevention Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Disease Control and Prevention Vaccine
Figure 2. Global Disease Control and Prevention Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Live-Attenuated Product Picture
Figure 4. Inactivated Product Picture
Figure 5. Recombinant Sub Unit and Toxoid Product Picture
Figure 6. Global Disease Control and Prevention Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 7. Pediatric Vaccine
Figure 8. Adult Vaccine
Figure 9. Global Disease Control and Prevention Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Disease Control and Prevention Vaccine Sales Capacity (K Units) (2015-2026)
Figure 11. Global Disease Control and Prevention Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Disease Control and Prevention Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Disease Control and Prevention Vaccine Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Disease Control and Prevention Vaccine Revenue in 2019
Figure 15. Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2015-2020)
Figure 17. Global Disease Control and Prevention Vaccine Sales Market Share by Region in 2019
Figure 18. Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2015-2020)
Figure 19. Global Disease Control and Prevention Vaccine Revenue Market Share by Region in 2019
Figure 20. North America Disease Control and Prevention Vaccine Sales Market Share by Country in 2019
Figure 21. North America Disease Control and Prevention Vaccine Revenue Market Share by Country in 2019
Figure 22. U.S. Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Disease Control and Prevention Vaccine Sales Market Share by Country in 2019
Figure 27. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country in 2019
Figure 28. Germany Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Disease Control and Prevention Vaccine Sales Market Share by Region in 2019
Figure 39. Asia Pacific Disease Control and Prevention Vaccine Revenue Market Share by Region in 2019
Figure 40. China Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Disease Control and Prevention Vaccine Sales Market Share by Country in 2019
Figure 63. Latin America Disease Control and Prevention Vaccine Revenue Market Share by Country in 2019
Figure 64. Mexico Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Country in 2019
Figure 72. Turkey Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Disease Control and Prevention Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Disease Control and Prevention Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Disease Control and Prevention Vaccine by Type (2015-2020)
Figure 79. Sales Market Share of Disease Control and Prevention Vaccine by Type in 2019
Figure 80. Revenue Share of Disease Control and Prevention Vaccine by Type (2015-2020)
Figure 81. Revenue Market Share of Disease Control and Prevention Vaccine by Type in 2019
Figure 82. Global Disease Control and Prevention Vaccine Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2015-2020)
Figure 84. Global Disease Control and Prevention Vaccine Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Disease Control and Prevention Vaccine by Application (2015-2020)
Figure 86. Global Revenue Share of Disease Control and Prevention Vaccine by Application in 2020
Figure 87. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Merck & Co., Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. AstraZeneca PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Sinovac Biotech Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Astellas Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Serum Institute of India Pvt. Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Price Trend of Key Raw Materials
Figure 97. Manufacturing Cost Structure of Disease Control and Prevention Vaccine
Figure 98. Manufacturing Process Analysis of Disease Control and Prevention Vaccine
Figure 99. Disease Control and Prevention Vaccine Industrial Chain Analysis
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. North America Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. North America Disease Control and Prevention Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Disease Control and Prevention Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Disease Control and Prevention Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Disease Control and Prevention Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Disease Control and Prevention Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs